Pfizer cuts vaccine price for poor as GAVI group seeks $7.5 bln
January 26, 2015 at 16:00 PM EST
LONDON, Jan 26 (Reuters) - Pfizer is to cut the price of its pneumococcal vaccine Prevenar 13 by 6 percent to $3.10 per dose in poor countries as part of a commitment to the GAVI global vaccines alliance, the U.S. drugmaker said on Monday.
